Interventional Radiology

Interventional radiology uses tools like embolization devices to provide minimally invasive medical diagnosis and treatment using images.

Omega Medical Imaging has announced the release of the revolutionary Soteria.AI.
News | Interventional Radiology
Omega Introduces Soteria.AI Interventional Cardiology System

April 27, 2022 – Omega Medical Imaging has announced the release of the revolutionary Soteria.AI. Designed specifically ...

Home April 27, 2022
Home
Philips Image Guided Therapy System
News | Cath Lab
Philips Signs Long-term Strategic Partnership with Oulu University Hospital Finland to Deliver Advanced Image-guided Specialist Care

April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...

Home April 18, 2022
Home
Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the publication of results from the first-in-human clinical trial of Embrace Hydrogel Embolic System (HES) for the treatment of hypervascular tumors, in the Journal of Vascular and Interventional Radiology (JVIR).
News | Embolization devices
Instylla First-In-Human Clinical Trial Published Results Demonstrate Technical Success and Persistent Embolization Across All Patients

March 31, 2022 – Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...

Home March 31, 2022
Home
Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, has received US Food and Drug Administration (FDA) clearance for its Solus Gold Embolization Device, a next-generation product for peripheral vascular occlusion.
News | Embolization devices
Artio Medical Receives FDA Clearance for Solus Gold Embolization Device

March 29, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral ...

Home March 29, 2022
Home
Arineta created a dedicated cardiac CT scanner in partnership with GE Healthcare a couple years ago. With increased interest in CTA with the new chest pain guidelines, the company decided to also start direct sales of these systems for the first time at RSNA in their own booth. Photos by Dave Fornell
Feature | RSNA | By Dave Fornell, DAIC Editor
6 Takeaways in Cardiac and Vascular Imaging at RSNA 2021

Here are a few of the key takeaways on the new technologies that will impact cardiovascular and interventional medicine ...

Home January 19, 2022
Home
With the advent of endovascular technology in the 1990s, carotid angioplasty and stenting (CAS) emerged as an alternative mode of revascularization.
News | Stents Carotid
Transcarotid Artery Revascularization (TCAR) Versus Carotid Endarterectomy (CEA) Cost-Effectiveness Shows Benefit for Stenting

January 5, 2022 – A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for ...

Home January 05, 2022
Home
The Philips CavaClear IVC Filter Removal Laser Sheath showing how it hooks to the filter and the laser follows the IVC structure down to where it is anchored in scar tissue. It uses a CO2 laser to dissolve the issue and release the device so it can be sheathed and removed from the body.
News | Cath Lab
FDA Clears Philip CavaClear Laser Assisted IVC Filter Removal System

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology, which are transcatheter devices used to seal brain aneurysms. The company said there is a risk of the delivery system’s wire and tubes fracturing and breaking off when the system is being used to place, retrieve, or move the stent inside a patient.
News | Cath Lab
Medtronic Recalls Neurovascular Pipeline Flex Embolization Devices for Risk of Fractures During Placement, Retrieval or Movement of Device

September 21, 2021 — Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device ...

Home September 21, 2021
Home
Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center of the Johannes Gutenberg University of Mainz comparing use of the EkoSonic Endovascular System in combination with anticoagulation to anticoagulation alone for the treatment of acute, intermediate-high-risk pulmonary embolism (PE).
News | Pulmonary Embolism
Study Compares Interventional Pulmonary Embolism Therapy in Combination With Anticoagulation to Anticoagulation Alone

August 9, 2021 — Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative ...

Home August 09, 2021
Home
News | Vena Cava Filters
Philips Receives FDA Breakthrough Device Designation for Laser Assisted IVC Filter Removal Device

July 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to a laser ...

Home July 27, 2021
Home
The Robocath R-One cath lab robotic platform being used in Rouen, France, to guide a cardiac Cath procedure. The system gained European approval in 2019. Robocath is now partnering with Philips France and Rennes University Hospital to develop the robotic system to treat strokes.
News | Stroke
Robocath, Philips and Rennes University Hospital Codevelop Robotic Stroke Intervention System

July 7, 2021 – Robocath, a company that designs, develops and commercializes cath lab robotic solutions to treat ...

Home July 07, 2021
Home
The FDA’s market clearance occurred once the agency reviewed EnsiteVascular’s Section 510(k) premarket notification of intent to market the SiteSeal SV device and determined it is substantially equivalent for the indication for use stated: brachial artery closure. Previously, EnsiteVascular received FDA market clearance for SiteSeal SV for radial artery closure.
News | Hemostasis Management
FDA Clears SiteSeal SV Vascular Closure Device for the Brachial Arteries

April 21, 2021 — EnsiteVascular announced it received its second U.S. Food and Drug Administration (FDA) market ...

Home April 21, 2021
Home
Rapid Medical's TigerTrieve stent-retriever neuro thrombectomy system.
News | Stroke
Thrombectomy Market Will Grow With Newly Approved Adjustable Stent Retriever

April 7, 2021 — Market research firm GlobalData's new report, Neurovascular Thrombectomy Devices (Neurology Devices), sh ...

Home April 07, 2021
Home
Virtual tour views of a University of Colorado cath lab during a CTO procedure (top left), the new robotic EP lab at Banner Health (top right), a bi-plane EP/cath combo lab at Baylor Heart Hospital Dallas (bottom left, and an ECMO procedure at Tufts Medical Center cath lab. Photos by Dave Fornell
Feature
Virtual Tours of Cath and EP Labs

There is a lot of interest in how other hospitals organize and equip their cardiac cath labs and electrophysiology (EP) ...

Home March 25, 2021
Home
Boston Scientific's TheraSphere Y-90 Glass Microspheres enable selective internal radiation therapy (SIRT), or radioembolization, for hepatocellular carcinoma. This treats liver cancer with low toxicity using millions of microscopic glass beads containing radioactive yttrium (Y-90), delivered directly to liver tumors via catheter. The result in minimal radiation exposure to surrounding healthy tissue.
News | Interventional Radiology
FDA Clears Boston Scientific TheraSphere Y-90 Transcatheter Liver Embolization Microspheres

March 18, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's TheraSphere Y-90 Glass ...

Home March 18, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now